跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MIRAPEXIN 2,1 MG COMPRIMIDOS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MIRAPEXIN 2,1 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Approved
STANDARD
MIRAPEXIN 2,1 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Boehringer Ingelheim International Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 10, 2024
Approval ID
d83ec6a71b5356b5
Company
Boehringer Ingelheim International Gmbh
Type
Standard
Approval Details
Approval Id
d83ec6a71b5356b5
Drug Cima Aemps Name
MIRAPEXIN 2,1 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Register Number
97051023IP3
Holder Company Name
Boehringer Ingelheim International Gmbh
Marketing Company Name
Ecofar Productos S.L.
Holder Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Authorization Date
2024-12-10
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
2,1 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Boehringer Ingelheim International Gmbh
Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Company Information
Pharmaceutical Company Name
Boehringer Ingelheim International GmbH
Country Name
Germany
City Name
ingelheim am rhein,rheinland-pfalz,country_de
Address
Binger Straße 173
Website
http://www.boehringer-ingelheim.com
Active Ingredients
PRAMIPEXOL
2,1 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 10, 2024
Approval ID
d83ec6a71b5356b5
Type
Standard
Back to CIMA-AEMPS Approvals